Randomization access [Regulatives / Guidelines]

posted by ElMaestro  – Denmark, 2015-08-10 11:51 (3973 d 22:40 ago) – Posting: # 15208
Views: 5,901

Hi bkrao,

❝ My question is whether the treatment randomization is accessable to the bioanalytical persons before the intioation of the bioanalytial phase.


Usually, BE studies are open-label and control of the rand. code is thus not extremely crucial, but it is a good habit in the industry to keep the rand. code away from bioanalysts. Most companies I know of state that bioanalysts are actually kept blind, both in protocols and SOPs. I think this is a very healthy principle but it is not specifically regulated by a guideline.

Pass or fail!
ElMaestro

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
368 visitors (0 registered, 368 guests [including 21 identified bots]).
Forum time: 10:32 CEST (Europe/Vienna)

Don’t compromise yourself.
You are all you’ve got.    Janis Joplin

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5